Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

H. W. Nam, V. M. Karpyak, D. J. Hinton, J. R. Geske, A. M.C. Ho, M. L. Prieto, J. M. Biernacka, M. A. Frye, R. M. Weinshilboum, D. S. Choi*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience